AIMS: Cognitive decline in Alzheimer's disease (AD) patients has been linked to synaptic damage and neuronal loss. Hyperphosphorylation of tau protein destabilizes microtubules leading to the accumulation of autophagy/vesicular material and the generation of dystrophic neurites, thus contributing to axonal/synaptic dysfunction. In this study, we analyzed the effect of a microtubule-stabilizing compound in the progression of the disease in the hippocampus of APP751SL/PS1M146L transgenic model. METHODS: APP/PS1 mice (3 month-old) were treated with a weekly intraperitoneal injection of 2 mg/kg epothilone-D (Epo-D) for 3 months. Vehicle-injected animals were used as controls. Mice were tested on the Morris water maze, Y-maze and object-recogn...
Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alz...
Amyloid-β (Aβ) and hyperphosphorylated tau (P-tau) are Alzheimer’s disease (AD) biomarkers that inte...
Transgenic mice expressing mutant human amyloid precursor protein (APP) develop an age-dependent am...
Aims: Cognitive decline in Alzheimer's disease (AD) is highly related to synaptic/neuronal loss. Tau...
Aims Cognitive and memory decline in Alzheimer's disease (AD) patients is highly related to synapti...
Cognitive decline in Alzheimer's disease (AD) is highly related to synaptic dysfunction and neuronal...
In Alzheimer’s disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
In Alzheimer's disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
In Alzheimer's disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
Dendritic spines represent the major postsynaptic input of excitatory synapses. Loss of spines and c...
Alzheimer's disease (AD) is the most frequent form of dementia in the elderly and no effective treat...
Evaluation of biomarkers and new innovative therapies for Alzheimer's disease (AD) suffers from a mi...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by initial memory...
Background: EphA4 is a receptor of the ephrin system regulating spine morphology and plasticity in t...
Neuroprotection of erythropoietin (EPO) following long-term administration is hampered by the associ...
Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alz...
Amyloid-β (Aβ) and hyperphosphorylated tau (P-tau) are Alzheimer’s disease (AD) biomarkers that inte...
Transgenic mice expressing mutant human amyloid precursor protein (APP) develop an age-dependent am...
Aims: Cognitive decline in Alzheimer's disease (AD) is highly related to synaptic/neuronal loss. Tau...
Aims Cognitive and memory decline in Alzheimer's disease (AD) patients is highly related to synapti...
Cognitive decline in Alzheimer's disease (AD) is highly related to synaptic dysfunction and neuronal...
In Alzheimer’s disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
In Alzheimer's disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
In Alzheimer's disease (AD), and other tauopathies, microtubule destabilization compromises axonal a...
Dendritic spines represent the major postsynaptic input of excitatory synapses. Loss of spines and c...
Alzheimer's disease (AD) is the most frequent form of dementia in the elderly and no effective treat...
Evaluation of biomarkers and new innovative therapies for Alzheimer's disease (AD) suffers from a mi...
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by initial memory...
Background: EphA4 is a receptor of the ephrin system regulating spine morphology and plasticity in t...
Neuroprotection of erythropoietin (EPO) following long-term administration is hampered by the associ...
Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alz...
Amyloid-β (Aβ) and hyperphosphorylated tau (P-tau) are Alzheimer’s disease (AD) biomarkers that inte...
Transgenic mice expressing mutant human amyloid precursor protein (APP) develop an age-dependent am...